| PCT, International Applications |
Referenced Items (388, 389, 390, 391, 392, 393, 394, 395, 396, 397, 398, 399, 400, 401, 402, 403, 404, 405, 406, 407, 408, 409, 410, 411, 412, 413, 414) |
(407) Notice Concerning European Patent Office
Competence to Act as a
Patent Cooperation Treaty Authority
The European Patent Office (EPO) has notified the International
Bureau of the World Intellectual Property Organization (WIPO) and the
United States Patent and Trademark Office (USPTO) that the EPO will
resume its competence to act as both an International Searching
Authority and an International Preliminary Examining Authority for
applications relating to the fields of biotechnology and
telecommunications filed by applicants who are U.S. residents or
nationals. However, the EPO will continue not to be a
competent International Searching Authority and an International
Preliminary Examining Authority for business methods applications. For
the definition of what the EPO considers to be precluded subject matter
in the field of business methods, applicants should see the "Notice
from the President of the European Patent Office" dated 26 November
2001, and which is attached to this Notice as Annex A. The text of the
letter is attached to this Notice as Annex B.
The EPO will resume acting as a competent International Searching
Authority (ISA), within the meaning of PCT Article 16(3), for
international applications filed by U.S. residents or nationals on or
after 01 January 2004 in the USPTO or International Bureau (IB) as
receiving Office, and where the application contains one or more claims
directed to the field of biotechnology. However, the EPO will
not be a competent ISA for international applications filed
by U.S. residents or nationals in the USPTO or International Bureau
(IB) as receiving Office on or after 01 March 2002 and before 01
January 2004, where the application contains one or more claims
directed to the field of biotechnology. See Notice Concerning EPO
Competence to Act as PCT Authority, 1255 Off. Gaz. Pat.
Office 878 (Feb. 19, 2002). Furthermore, the EPO will continue
not to be a ISA, within the meaning of PCT Article 16(3),
for international applications filed by U.S. residents or nationals on
or after 01 March 2002 in the USPTO or International Bureau (IB) as
receiving Office, and where the application contains one or more claims
directed to the field of business methods.
The EPO will resume acting as a competent International
Preliminary Examining Authority (IPEA), within the meaning of PCT
Article 32(3), for international applications filed by U.S. residents
or nationals on or after 01 January 2004 in the USPTO or IB as
receiving Office, where the application contains one or more claims
directed to the field of biotechnology and where the EPO acted as the
ISA. However, the EPO will not be a competent IPEA for
international applications filed before 01 January 2004 by U.S.
residents or nationals in the USPTO or International Bureau (IB) as
receiving Office where the corresponding demand was filed with the EPO
on or after 01 March 2002, where the application contains one or more
claims directed to the field of biotechnology.
As of 01 July 2004, the EPO will resume acting as a competent
IPEA, within the meaning of PCT Article 32(3), for demands filed by
U.S. residents or nationals on or after 01 July 2004 for international
applications filed in the USPTO or IB as receiving Office, where the
application contains one or more claims directed to the field of
telecommunication and where the EPO acted as the ISA. However, the EPO
will not be a competent IPEA for international applications
filed by U.S. residents or nationals in the USPTO or International
Bureau (IB) as receiving Office where the corresponding demand was
filed with the EPO on or after 01 March 2002 and before 01 July 2004,
where the application contains one or more claims directed to the field
of telecommunications.
 Top of Notices (407) December 27, 2022 |
US PATENT AND TRADEMARK OFFICE |
1505 CNOG 2771 |
The EPO will continue not to be a competent IPEA,
within the meaning of PCT Article 32(3), for international applications
filed by U.S. residents or nationals in the USPTO or IB as receiving
Office where the corresponding demand is filed with the EPO on or after
01 March 2002, and where the application contains one or more claims
directed to the field of business methods. This limitation applies to
all demands received at the EPO on or after 01 March 2002 including
demands in applications that were filed before 01 March 2002 for which
the EPO was still the competent ISA.
Residents or nationals of the U.S. should not select the EPO
as the ISA/IPEA when filing applications in the field of business
methods nor select the EPO as the IPEA prior to 01 July 2004 when
filing a demand in an international application in the field of
telecommunications. The classification of an international application
is a function of the ISA (PCT Rule 43.3(b)), and as such, the United
States Receiving Office (RO/US) has neither the resources nor the
authority to determine if applications fall within the above
International Patent Classification Units. Therefore, the RO/US will
rely solely on applicant determinations as to the area of
classification and the resulting competency of the EPO, and as such,
the RO/US will forward to the EPO all applications in which the EPO is
indicated as the ISA/IPEA in our normal course of doing business.
STEPHEN G. KUNIN
Deputy Commissioner for
Patent Examination Policy
Annex A
Notice from the President of the European Patent Office dated
26 November 2001 concerning limitation of the EPO's competence as a PCT
authority
Limitation criteria
1. Pursuant to Article 3(4)(a)(ii) of the PCT Agreement between the
European Patent Organization and the International Bureau of the World
Intellectual Property Organization, as amended with effect from 1
November 2001 (OJ EPO 2001,601), the European Patent Office (EPO) will
not carry out
(a) international search in respect of any international application
filed on or after 1 March 2002 by a national or resident of the United
States of America with the United States Patent and Trademark Office
(USPTO) or the International Bureau (IB) as receiving Office where such
application contains one or more claims relating to the fields of
biotechnology or business methods, as defined by the International
Patent Classification units indicated below in paragraphs 3 and 4.
(b) international preliminary examination in respect of any
international application filed by a national or resident of the United
States of America with the USPTO or the IB as receiving Office where
the corresponding demand is filed with the EPO on or after 1 March 2002
and the application contains one or more claims relating to the fields
of biotechnology or business methods as referred to in sub-paragraph
(a) above or to the field of telecommunication as defined by the
International Patent Classification unit indicated below in paragraph
5.
2. Without prejudice to the right of the EPO to issue any further
notice under Article 3(4) of the PCT Agreement which it may consider
necessary, the initial duration of these limitations will be three
years (Article 3(4)(c) of the PCT Agreement).
| Top of Notices (407) December 27, 2022 |
US PATENT AND TRADEMARK OFFICE |
1505 CNOG 2772 |
International Patent Classification
3. Biotechnology
C12M Apparatus for enzymology or microbiology
C12N Micro-organisms or enzymes; compositions thereof
C12P Fermentation or enzyme-using processes to synthesise a
desired chemical compound or composition or to separate
optical isomers from a racemic mixture
C12Q Measuring or testing processes involving enzymes or
micro-organisms; compositions or test papers therefor;
processes of preparing such compositions; condition-
responsive control in microbiological or enzymological
processes
C07K Peptides
G01N33/50 (including subdivisions) Chemical analysis of
biological material, e.g. blood, urine; testing involving
biospecific ligand binding methods; immunological testing
A61K39 Medicinal preparations containing antigens or
antibodies
A61K48 Medicinal preparations containing genetic material
which is inserted into cells of the living body to treat
genetic diseases; gene therapy
A01H New plants or processes for obtaining them; plant
reproduction by tissue culture techniques
For information: U.S. classes covering corresponding subject-matter
424 Drug, bio-affecting and body treating compositions
435 Chemistry: molecular biology and microbiology
436 Chemistry: analytical and immunological testing
514 Drug, bio-affecting and body treating compositions
530 Chemistry: natural resins or derivatives; peptides or
proteins; lignins or reaction products thereof
536 Organic compounds-part of the class 532-570 series
800 Multicellular living organisms and unmodified parts thereof
930 Peptide or protein sequence
4. Business method related inventions
GO6F17/60 Digital computing or data processing equipment or
methods, specially adapted for specific functions:
administrative, commercial, managerial, supervisory or
forecasting purposes. If an application falls within this
subgroup but does not relate to business methods, the EPO's
competence is not affected.
For information: U.S. class covering corresponding subject-matter
| Top of Notices (407) December 27, 2022 |
US PATENT AND TRADEMARK OFFICE |
1505 CNOG 2773 |
705 Data processing: financial, business practice, management, or
cost/price determination
5. Telecommunication
H04 Electric communication technique with the exception of
H04N: pictorial communication, e.g. television
For information: U.S. classes covering corresponding subject-matter
370 Multiplex communications
375 Pulse or digital communications
379 Telephonic communication
380 Cryptography
381 Electrical audio signal processing systems and devices
455 Telecommunications
Notes
6. The EPO is no longer the competent authority within the meaning of
Article 16(3)(b)1 and Article 32(3)2 PCT for applications meeting the
criteria defined in paragraph 1.
7. Paragraph 1 also applies to applications filed with the IB
rather than the USPTO by two or more applicants,
- at least one of whom is a national or resident of the USA, and
- none of whom are nationals or residents of an EPC contracting state.
8. It is not possible to reassign competence to the EPO by
changing the applicant after the application has been filed with the
USPTO or the IB.
9. The limitation criteria in paragraph 1(b) apply to all
demands for international preliminary examination received at the EPO
on or after 1 March 2002 (sic), which means they are also applicable to
applications filed before 1 March 2002 for which the EPO was still the
competent International Searching Authority.
1 The receiving Office deletes the indication of any
non-competent International Searching Authority ex officio (Receiving
Office Guidelines, No. 115, PCT Gazette - IV, 29 of 17 September 1998).
2 Demands for international preliminary examination
submitted to a non-competent authority are subject to Rule 59.3 PCT.
Annex B
Mr. James E. Rogan
Director of the United States Patent and Trademark Office
US Department of Commerce
Box 4
WASHINGTON, D.C. 20231 U.S.A.
BY FAX: +1-703 305 8664
Zeichen/Reference/Reference
57.8.10/11
Datum/Date/Date
31.10.2003
| Top of Notices (407) December 27, 2022 |
US PATENT AND TRADEMARK OFFICE |
1505 CNOG 2774 |
Dear Mr Rogan,
I refer to the notice dated 26 November 2001 issued pursuant to Article
3(4)(aii) of the Agreement between the EPO and WIPO under the POT (OJ
EPO 1/2002, 52, copy enclosed) and now wish to advise you that
paragraphs 1(a) and (b) of that notice are to be amended as follows:
The reference to the field of biotechnology is deleted from paragraphs
1(a) and (b) with effect for all international applications filed from
1 January 2004 and the reference to the field of telecommunication is
deleted from paragraph 1(b) with effect for all demands filed as from 1
July 2004.
The effect of these changes is that the EPO will resume its competence
as International Seaching Authority and International Preliminary
Examining Authority for international applications filed as from 1
January 2004 by nationals or residents of the United States of America
where such applications contain one or more claims relating to the
field biotechnology as defined by the International Patent
Classification Unit indicated in paragraphs 3 and 4 of the notice.
The EPO wifl also resume its competence as as lnternational Preliminary
Examining Authority in respect of international applications filed by
nationals or residents of the United States of America containing one
or more claims relating to the field of telecommunications as defined
by the International Patent Classification Unit indicated in paragraph
5 of the notice where the corresponding demand is filed on or after 1
July 2004.
The reference to the field of business methods in both paragraphs 1(a)
and (b) remains intact and the EPO is not competent to act as
International Searching Authority or International Preliminary
Examining Authority in respect of such applications for the remainder
of the term specified in paragraph 2 of the notice.
In all other respects the notice remains in full force and effect. I
have today written in similar terms to Dr. Idris, Director General of
WIPO, requesting that this information be disseminated via the usual
WIPO channels. I would ask that you undertake the appropriate steps to
bring this information to the attention of US applicants. This
information will also be published in the Official Journal of the EPO.
Yours sincerely,
Dr h.c. Ingo Kober
President
INTERNATIONAL VERTRAGE INTERNATIONAL TREATIES TRAITES INTERNATIONAUX
PCT PCT PCT
Mitteilung des Prasi- Notice from the Communique du Presi-
denten des Europaischen President of the dente del'Office euro-
Patentmts vom 26. No- European Patent Office peaen des brevets, en
vember 2001 ubar die dated 26 November date du 26 novembre
Beschrankung der Zus- 2001 concerning limi- 2001, relatif Ala
tandigkeit des Euro- tation of the EPO's limitation de la
paischen Patentamts als competence as a PCT competence de l'Office
PCT-Behorde authority europeen des brevets
agissant en qualite
d'administration au
titre du PCT
Beschrankungskriterien Limitation criteria Criteres de limitation
1. Nach Artikel 3(4)ii) 1. Pursuant to Article 1. Conformement a
| Top of Notices (407) December 27, 2022 |
US PATENT AND TRADEMARK OFFICE |
1505 CNOG 2775 |
der mit Wirkung vom 1. 3(4)(ii) of the PCT l'article 3, paragraphe
November 2001 (ABI.EPA Agreement bewtween the (4)a)ii) de l'accord
2001, 601) geanderten European Patent Organi- entre l'Organisation
PCT-Vereinbarung sation and the Interna- europeene des brevets
zwischen der Europai- tional Bureau of the et le Bureau interna-
schen Patentorganisa- World Intellectual tional de l'Organisa-
tion und dem Interna- Property Organization, tion Mondiale de la
tionalen Buro der as amended with effect Propriete Intellectu-
Weltorganisation fur from 1 November 2001 elle au titre du PCT,
geistiges Eigentum (OJ) EPO 2001, 601), tel que modifie avec
fuhrt das Europaische the European Patent affet au 1st novembre
Patentamt (EPA) nicht Office (EPO) will not 2003 (JO OEB, 2001,
durch carry out 601), l'Office europeen
des brevets (OEB)
n'effectuera pas
a) die internationale (a) international a) la recherche inter-
Recherche fur eine search in respect of nationale a l'egard de
internationale Anmel- die any international toute demande interna-
dung, am oder nach dem application filed on or tionale deposee aupres
1. Marz 2002 von dinem after 1 March 2002 by a del'Office des brevets
Staatsangehorigen Verei national or resident of et des marques de
nigten Staaten von the United States of Etats-Unis (USPTO) ou
Amerika oder einem America with the United du Bureau international
Anmelder, der dort States Patent and (BI) en qualite
seinen Sitz oder Trademark Office d'office recapteur a
Wohnsitz hat, bein (USPTO) or the Inter- partir du 1st mars 2002
Patent- und Markenamt natinal Bureau (IB) as par une personne de
der VereinigtenStaaten receiving Office where nationalite americaine
(USPTO) oder beim such application ou residant aux Etats-
Internationalen Buro contains one or more Unis d'Amerique,
(IB) als Anmeldeamt claims relating to the lorsque la demande de
eingereicht wird, wenn fields of biotechnology brevet contient une ou
diese Anmeldung einen or business methods, as plusieurs revendica-
oder mehrere Anspruche defined by the Interna- tions se rapportant a
enthalt, die sich auf tional Patent Classifi- labiotechnologie ou a
Biotechnologieoder cation units indicated des methodes commercia-
Geschaftsmethoden gemaB below in paragraphs 3 les, telles que
der Definition der and 4. definies par les unites
Einheiten der Interna- de la Classification
tionalen Patentklassi- internationale des
fikation in den brevets enumerees aux
nachstehenden Absatzen points 3 et 4 ci
3 und 4 beziehen; dessous.
b) die internationale (b) international pre- b) l'examen prelimi-
vorlaufige Prufung fur liminary examination in naire international a
eine internationale respect of any interna- l'egard de toute demand
Anmeidung, die von tional application interationale deposee
einem Staatsangehorigen filed by a national or aupres de l'USPTO ou du
der Vereingten Staaten resident of the United BI en qualite d'office
von Amerika oder eniem States of America with recepteur par une
Anmelder,der dort the USPTO or the IB as personne denationalite
seinen Sitz oder receiving Office where americaine ou resi-
Wohnsitz hat, beim the corresponding dantaux Etats-Unis
USPTO oder beim IB als demand isfiled with the d'Amerique, torsque la
Anmeldeamt eingereicht EPO on or after 1 March demande d'examen est
wird, wenn der 2002 and the applica- presentee aupres de
entsprechende Antrag am tion contains one or l'OEB a partir du 1st
oder nacht dem 1. Marz more claims relating 2002 et que la demande
2002 beim EPA to the fields of bio- de brevet contient une
eingereicht wird und technology or business ou plusieurs revendica-
die Anmeldung einen methods as referred to tions se rapportant a
oder mehrere Anspruche in sub-paragraph (a) la biotechnologie ou a
enthal, die sich gemaB above or the field of des methodes commer-
Buchstabe a auf Biotech- telecommunication as ciales conformement au
| Top of Notices (407) December 27, 2022 |
US PATENT AND TRADEMARK OFFICE |
1505 CNOG 2776 |
nologie oder defined by the point a) ci-dessus,
Geschaftsmethoden oder International Patent ou au domaine des
gemaB der Definition Classification unit telecommunications
der Einheit der Inter- indicated below in telque de fini dans
nationlen Patentklassi- paragraph 5. l'unite de la Classi-
fikation im fication internationale
nachstehanden Absatz 5 des brevets indiquee au
auf Telekommunikation pointe ci-dessous.
beziehen.
2. Die anfangliche 2. Without prejudice to 2. Sans prejudice du
Geltungsdauer dieser the right of the EPO to droit de l'OEB
Beschrankungen betragt issue any further notice d'emettra toute autre
drei Jahre (Artikel 3 under Article 3(4) of notification visee a
(4) c) der PCT-Verein- the PCT Agreement which l'article 3(4) de
barung); das Recht des it may consider neces- l'accord au titre du
EPA, weitere von ihm sary, the initial PCT qu'il juge
fur notwendig erachtete duration of these limi- necessaire,la duree
Mitteilungen nach tations will be three initials de ces
Artikel 3 (4) der PCT- years (Article 3(4)(c) limitations est de
Vereinbarung ergahen of the PCT Agreement). trois ans (article
zu lassen, bleibt davon 3(4)c) de l'accord au
unberuhrt. titre du PCT).
Internationale International Classification
Patentlkassifikation Patent Classification internationale
desbrevets
3. Biotechnologie 3. Biotechnology 3.Biotechnologie
C12M Vorrichtungen fur C12M Apparatus for C12M Appareillage pour
Enzymologie oder enzymology or micro- l'enzymologie ou la
Mikrobiologie giology microbiologie
C12N Mikoorganismen C12N Micro-organism or C12N Micro-organismes
oder Enzyme; Zusam- enzymes; compositions ou enzymes; composi-
mensetzungen aus thereof tions les contenant
Mikroorganismen oder C12P Fermentation or C12 Procedes de
Enzymen enzyme-using processes fermentation ou
C12P Garungsverfahren to synthesise a procedes utilisant des
oder Verfahren unter desired chemical enzymes pour la syn-
Verwendung von Enzymen compound or composi- these d'un compose
zur gezielten tion or to separate chimique donne ou
Synthsesvon chemischen optical isomers from d'une composition
Verbindungen oder a recemic mixture donnee, ou pour la
Zusammensetzungen oder C12Q Measuring or separation d'isomeres
zur Trennung optishcer testing processes optiques a partir d'un
isomerer aus einer involving enzymes or melange racemique
racemischen Mischung microorganism; C12Q Procedes de mesure,
C12Q MeB-oder Unter- compositions or test de recherche ou
suchungsverfahren papers therefor; d'analyse faisant
unter Einbeziehung von processes of preparing intervenir des enzymes
Enzymen oder Mikro- such compositions; ou des
organismen; condition-responsive microorgansimes;
Zusammensetzungen oder control in microbio- composititions ou
Testpapiere hierfur, logical or enzymo- papiers reactifs a cet
Verfahren zum Herst- logical processes effet; procedes pour
ellen derartiger C07K Peptides preparer ces composi-
Zusammensetzungen; G01N33/50 (including tions; procedes de
Steuern in Abhangig- subdivisions) commande sensiblesaux
keit von den Ver- Chemical analysis of conditions du millieu
fahrensbedingungen bei biological material, dans les procedes
mikrobiologischan oder eg blood, urine; microbiologiques ou
enzymologischen testing involving enzymologiques
Verfahren biospecific ligand C07K Peptides
C07K Peptide binding methods; G01N33/50
G01N33/50 immunological testing (y conpris sous-
| Top of Notices (407) December 27, 2022 |
US PATENT AND TRADEMARK OFFICE |
1505 CNOG 2777 |
(einschlieBlich A61K39 Medicinal divisions)
Untereinheiten preparations Analyse chimique de
Chemische Analyse von containing antigens or materiau biologique,
biologischen Stoffen, antibodies p.ex.de sang, d'urine;
z. B. Blut, Urin; A61K48 Medicinal recherche ou analyse
Untersuchung unter preparations contain- par des methodes
Anwendung biospez- ing genetic material faisant intervenir la
fischer Liganden- which is inserted into formation de liaisons
bindungsverfahren; cells of the living biospecifiques par
immunologische Unter- body to treat genetic ligands, recherche ou
suchungsverfahren diseases; gene therapy analyse immunologique
A61K39 Medizinische A01H New plants or A61K39 Preparations
Praparate die Antigene processes for medicinales contenant
oder Antikorper obtaining them; plant des antigenes ou des
enthalten reproduction by tissue anticorps
A61K48 Medizinische culture techniques A61K48 Preparations
Zubereitungen, die medicinales contenant
genetische Material du material genetique
enthalten, das in qui est introduit dans
Zellen des lebenden des cellules du corps
Korpers eingefuhrt vivant pour traiter
wird, um genetisch des maladies geneti-
bedingte Krankheiten ques; therapie genique
zubehandeln; A01H Nouveautes
Gentherapie vegetales ou procedes
A01H Neue Pflanzen oder pour leur obtention;
Verfahren zu deren reproduction de
Gewinnung; Pflanzen- plantes par des tech-
reproduction durch niques de culture des
Gewebekulturverfahren tissues
Zur Information: For information: Pour information:
US-Klassen, unter US classes covering classes US
die die entsprechenden corresponding couvrant les objects
Gegenstande fallen subject-matter correspondants
424 Arzneimittel, 424 Drug, bio-affecting 424 Compositions medic-
bioaktive und Korper- and body treating amensteuses, a effet
behandlungsmittel composition biologique et pour les
435 Chemie: Molekular- 435 Chemistry: soins du corps
biologie und Mikrobi- molecular biology and 435 Chimie: biologie
logie microbiology moleculaire et
436 Chemie:analytische 436 Chemistry: microbiologie
und immunologische analytical and immuno- 436 Chimie: essals ana-
Untersuchungsverfahren logical testing lytiques et analyses
514 Arzneimittel, 514 Drug, bio-affecting immunologiques
bioaktive und Korper- and body treating com- 514 Compositions
behandlungsmitte positions medicamenteuses, a
530 Chemie: naturliche 530 Chemistry: natural effet biologique et
Harze oder deren resins or derivatives; pour les soins du
Derivate; Peptide oder peptides or proteins; corps
Proteine; Lignine oder lignins or reaction 530 Chimie: resines
deren Reaktionspro- products thereof naturelles ou derives;
dukte 536 Organic compounds- peptidesou proteine
536 Organische part of the class lignines ou leurs
Verbindugen-Tell der 532-570 series produits de reaction
Klassenreihe 532-570 800 Multicellular 536 Composes
800 Mehrellige lebenda living organisms and organiques-partie des
Organismen und deren unmodified parts series desclasses
unveranderte Teil thereof 532-570
930 Peptid-oder 930 Peptide or protein 800 Organismes vivant
Proteinsequenzen sequence multicellulaires et
leure parties non
modifiees
930 Sequencesde
peptides oude
| Top of Notices (407) December 27, 2022 |
US PATENT AND TRADEMARK OFFICE |
1505 CNOG 2778 |
proteines
4. Erfindungen 4. Business 4. Inventions
betreffend method related relatives a des
Geschaftsmethoden inventions methodes commerciales
GO6F17/60 Digitale GO6F17/60 Digital GO6F17/60 Equipement
Rechen-oder Datenver- computing or data ou methodes de
arbeitungsanlagen processing equipment traitment de donnees
oder-verfahren, or methods, specially ou de calcul
besonders angepaBt an anadapted for specific numerique, speciale-
speezielle Anwendungen: functions: administra- ment adaptes a des
verwaltungstechnische, tive, commercial,mana- fonctions specifiques:
wirtschaftliche, gerial, supervisory or a des fins administra-
geschaftliche Zwecke, forecasting purposes. tives, commerciales,
Uberwachungs-oder If an application de gestion, de sur-
Voraus sagezwecks. falls within this veillance ou de
Soweit die Anmeldung subgroup but does not prevision. La com-
unter die vorstehend relate to businessn petence de l'OEB
genannte Untergruppe methods, the EPO's n'est pas affectee en
fallt, sich aber competence is not ce qui concerns les
nicht auf Geschafts- affected. demandes relevant de
methoden bezieht, ce sous-groupe, mais
bleibt die Zustandig- ne se rapportant pas a
keit des EPA unberuhrt des methodes
commerciales.
Zur Information: For information: Pour information:
US-Klasse, unter die US class covering classes US
die entsprechenden corresponding couvrant les objects
Gegenstande fallen subject-matter correspondants
705 Datenverabeitung: 705 Data processing: 705 Traitement de
Finanz-, Geschafts- financial, business donnees: gestion des
prazxis, Management practice management, comptes, pratiques
oder Kosten- or cost/price commerciales, gestion
Preisermittlun determination ou etablissement des
couts et des prix
5. Telekommunikation 5. Telecommunication 5. Telecommunications
H04 Elektrische H04 Eelctric H04 Technique de la
Nachrichtentechnik mit communication with communication elec-
Ausnahmetechnique von the exception of H04N: trique, a l'exception
H04N: Bildubertra pictorial communica- de H04N: transmission
gung, z. B. Fernsehen tion, eg television d'images, p.ex.
television
Zur Information: For Information: Pour information:
US-Klassen, unter US classes covering classes US couvrant
die die entsprechenden corresponding les objets
Gegenstande fallen subject-matter correspondents
370 Multiplexverkehr 370 Multiplex 370 Communications
375 Impuls-oder communications multiplex
Digitalverkehr 375 Pulseor digital 375 Communications
379 Fernsprechverkehr communications numeriques ou a
380 Krytographie 379 Telephonic impulsion
381 Elektrische Systeme communication 379 Communication
und Gerate fur die 380 Cryptography telephonique
Audiosignalverabeitung 381 Electrical audio 380 Cryptographie
455 Telekommunikation signal processing 381 Dispositifs et
systems and devices systemes de traitement
455 Telecommunications de signaux audio
| Top of Notices (407) December 27, 2022 |
US PATENT AND TRADEMARK OFFICE |
1505 CNOG 2779 |
electriques
455 Telecommunications
Erganzende Remarques
Erlauterungen Notes Complementaires
6. Fur Anmeldungen, 6. The EPO is no longer 6. Pour les demandes
die die in Absatz 1 the competent authority qui remplissent les
genannten Voraussetz within the meaning of conditions enoncees au
ungen erfullen, ist Article 16(3)(b)1 and point 1, l'OEB n'est
das EPA nicht mehr die Article 32(3)2 PCT for plus l'administration
zustandige internation- applications meeting internationale
ale Behorde im Sinne the criteria defined competente au sens de
von Artikel 16(3)b)1 in paragraph 1. l'article 16(3)b)1 et
und Artikel 32(3)2 PCT. de l'article 32(3)2
PCT.
7. Unter Absatz 1 7. Paragraph 1 also 7. Tombent egatement
fallen auch Anmel- applies to applications sous le regime du point
dungen, die statt beim filed with the IB 1, les demandes qui, au
USPTO beim IB von rather than the USPTO lieu d'etre deposees
mehreren Anmeldern by two or more aupres de l'USPTO sont
eingereicht werden, applicants, deposees aupres du BI
wenn par plusieurs
deposants, dont:
- mindestens - at least one of whom - l'un au moins est
ein Anmelder is a national or ressortissant des
Staatsangehoriger resident of the USA, Etats-Unis ou a son
der USA ist oder dort and siege ou domicile aux
seinen Sitz oder Etats-Unis;
Wohnsitz hat und
- kein Anmelder - none of whom are - aucun n'est ressor-
Staatsangehoriger nationals or residents tissant d'un Etat
eines EPU-Vertrags- of an EPC contracting partie a la CBE ou n'a
staats ist oder dort state. son siege ou domicile
seinen Sitz oder dans un de ces Etats.
Wohnsitz hat.
8. Die Zustandigkeit 8. It is not possible 8. La competence de
des EPA kann auch nicht to reassign competence l'OEB ne peut pas non
dadurch wiederher- to the EPO by changing plus etre retablie par
gestellt werden, daB the applicant after un changement de
nach Einreichung de the application has deposant apres le depot
Anmeldung beim USPTO been filed with the de la demande aupres de
oder IB ein Wechsel des USPTO or the IB. l'USPTO ou du BI.
Anmelders stattfindet.
9. Die Beschrankungs- 9. The limitation 9. Les criteres de
kriterien in Absatz criteria in paragraph limitation enonces au
1 b) gelten fur alle 1(b) apply to all point 1b) s'appliquent
Antrage auf interna- demands for interna- a toutes les demandes
tionale vorlaufige tional preliminary d'examem preliminaire
Prufung,die am oder examination received international recues
nach dem 1. Marz 2002 at the EPO on or after par l'OEB a partir
beim EPA eingehen 2, 1 March 2002 2, which du 1st mars 2002 2:
erfassen also auc means they are also ils s'appliquent dons
Anmeldungen, die vor applicable to applica- aussi aux demandes de
dem 1. Marz 2002 tions filed before 1 brevet deposees avant
eingereicht worden March 2002 for which le 1st mars 2002 et
sind und fur die das the EPO was still the pour lesquelles l'OEB
EPA noch zustandige competent International etait encore
internationale Searching Authority. l'administration
Recherchenbehorde war. competente chargee
de la recherche
| Top of Notices (407) December 27, 2022 |
US PATENT AND TRADEMARK OFFICE |
1505 CNOG 2780 |
internationale.
1 Des Anmaldeant 1 The receiving Office 1 L'Office recepteur
streicht von Amts wegen deletes the indication supprime d'office
die Angabe jeder unzus- of any non-competant l'indication de
tandugan Internation- International Searching toute administration
alen Recherchambehorde Authority ex officio chargee de la recherche
(Richtilien fur das (Receiving Office internationale qui
Anmeldeamt, Nr. 115, Guidelines, No. 115, n'est pas competente
PCT-Blatt-IV, 29 von PCT Gazette-IV, 29 of (Directives a l'usage
17, September 1998). 17 September 1998). des offices recepteurs,
no 115, Gazette du
PCT-IV, 29 du 17
septembre 1998).
2 Auf bei dar 2 Demands for interna- 2 La regle 59.3 PCT
unzustandigen Behorte tional preliminary c'applique aux demandes
singereichte Antrage examination submitted d'examen preliminaire
suf internationale to a non-competent international presentees
vorlaufige Prufung authority are subject supres d'une
findet to
[1277 OG 230]